国际皮肤性病学杂志    0  (): 381-383   ISSN: 2096-5540  CN: 32-1880/R   HHV-6、HHV-7和HHV-8与某些皮肤病的关系研究进展 王启华, 陈树民 山东省皮肤病性病防治研究所 济南 250022 收稿日期 2005-04-07  修回日期 null  网络版发布日期 null 参考文献  [1] Drago F, Ranieri E, Malaguti F, et al. Human herpesvirus 7 in pa tients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin.Dermatology, 1997, 195:374-378. [2] Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus7 and human herpesvirus-6. J Invest Dermatol, 2002, 119:793. [3] Vag T, Sonkoly E, Karpati S, et al. Avidity of antibodies to human herpesvirus 7 suggests primary infection in young adults with pityriasis rosea. J Eur Acad Dermatol Venereol, 2004, 18:738-740. [4] Drago F, Malaguti F, Ranieri E, et al. Human herpes virus-like particles in pityriasis rosea lesions:an electron microscopy study. J Cutan Pathol, 2002, 29:359-361. [5] Chuh AA, Chiu SS, Peiris JS. Human herpesvirus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction:a prospective case control study. Acta Derm Venereol, 2001, 81:289-290. [6] Chuh AA, Peiris JS. Lack of evidence of active human herpesvirus 7 (HHV-7) infection in three cases of pityriasis rosea in children. Pediatr Dermatol, 2001, 18:381-383. [7] Karabulut AA, Kocak M, Yilmaz N, et al. Detection of human her pesvirus 7 in pityriasis rosea by nested PCR. Int J Dermatol, 2002, 41:563-567. [8] Chuh AA, Chan HH, Zawar V. Is human herpesvirus 7 the causative agent of pityriasis rosea?-A critical review. Int J Dermatol, 2004, 43:870-875. [9] Grivel JC, Ito Y, Faga G, et al. Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med, 2001, 7:1232-1235. [10] Smith AP, Paolucci C, Di Lullo G, et al. Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol, 2005, 79:2807-2813. [11] Ablashi DV, Chatlynne LG, Whitman JE Jr, et al. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev, 2002, 15:439-464. [12] Kouri V, Eng SM, Rodriguez ME, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba. Rev Panam Salud Publica, 2004, 15:320-325. [13] Akula SM, Naranatt PP, Walia NS, et al. Kaposi's sarcoma-associ ated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol, 2003, 77:7978-7990. [14] Morelli L, Pusiol T, Piscioli F, et al. Herpesvirus 8-associated penile Kaposi's sarcoma in an HIV-negative patient:first report of a solitary lesion. Am J Dermatopathol, 2003, 25:28-31. [15] Cathomas G. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Herpes, 2003, 10:72-77. [16] Polstra AM, Cornelissen M, Goudsmit J, et al. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis. J Med Virol, 2004, 74:390-396. [17] Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet, 1988, 1:1065-1067. [18] Dockrell DH. Related. Human herpesvirus 6:molecular biology and clinical features. J Med Microbiol, 2003, 52:5-18. [19] Torigoe S, Kumamoto T, Koide W, et al. Clinical manifestations as sociated with human herpesvirus 7 infection. Arch Dis Child, 1995, 72:518-519. [20] Chuh AA, Chan HH, Chiu SS, et al. A prospective case control study of the association of Gianotti-Crosti syndrome with human herpesvirus 6 and human herpesvirus 7 infections. Pediatr Derma tol, 2002, 19:492-497. [21] Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia andsystemic symptoms. Arch Dermatol, 2001, 137:301-304. [22] Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol, 2004, 140:183-188. [23] Nakashima H, Yamane K, Ihn H, et al. Drug-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and increase in serum IgE level. Dermatology, 2005, 210:349-352. [24] Sekiguchi A, Kashiwagi T, Ishida-Yamamoto A, et al. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation. J Dermatol, 2005, 32:278-281. [25] Mitani N, Aihara M, Yamakawa Y, et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol, 2005, 75:430-434. 通讯作者: